Skip to main content
Contact Us
Subscribe
E-Edition
56°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Optinose Inc
(NQ:
OPTN
)
0.4800
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Optinose Inc
< Previous
1
2
3
4
5
Next >
OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023
March 07, 2024
OPTN stock results show that OptiNose met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
March 07, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
February 29, 2024
Conference Call and Webcast to be held March 7, 2024, at 8:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice
January 18, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
OptiNose's Earnings: A Preview
March 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 06, 2023
Via
Benzinga
Gold Moves Higher; Campbell Soup Earnings Top Expectations
December 06, 2023
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 06, 2023
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 06, 2023
Via
Benzinga
Crude Oil Down 4%; Pharvaris Shares Spike Higher
December 06, 2023
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
US Stocks Higher; Private Payrolls Rise By 103,000 In November
December 06, 2023
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why ENT-Focused OptiNose Shares Are Diving Today
December 06, 2023
OptiNose, Inc. (NASDAQ: OPTN) shares are trading lower after the company announced a three-month extension of the FDA review period for the supplemental new drug application for
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 06, 2023
Via
Benzinga
Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE
December 06, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
November 22, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Reports Third Quarter 2023 Financial Results and Operational Updates
November 09, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Third Quarter 2023 Financial Results
October 27, 2023
Conference Call and Webcast to be held November 9, 2023, at 8:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the 2023 Cantor Global Healthcare Conference
September 22, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023
August 21, 2023
Via
Benzinga
Optinose Reports Second Quarter 2023 Financial Results and Operational Updates
August 10, 2023
From
Optinose, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
July 28, 2023
Via
Benzinga
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
July 27, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 07, 2023
On Wednesday, 29 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
June 06, 2023
On Tuesday, 69 stocks hit new 52-week lows.
Via
Benzinga
Optinose to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
May 19, 2023
On Friday, 63 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 19, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.